Novagali eye Treatment for Vernal Keratoconjunctivitis (VKC) Successful in Phase III Trial novagali眼治療春季角結膜炎（ vkc ）成功地在第三階段試驗
Israeli-French drug development company Novagali SA, which was founded on the basis of research conducted by Prof. Simon Benita of the Hebrew University of Jerusalem, has successfully completed European Medicines Agency (EMEA) Phase III clinical trials of its eye treatment for Vernal Keratoconjunctivitis (VKC)..以色列-法國藥物開發公司novagali SA服務，這是基礎上建立的進行的研究教授西蒙貝妮塔的耶路撒冷希伯來大學，成功地完成了歐洲藥品管理局（ EMEA ）來第三階段的臨床實驗，其眼治療春季角結膜炎（ vkc ） ..
This is a rare form of chronic allergic conjunctivitis seen in children and characterized by ocular discomfort, pain, itching and intense photophobia (sensitivity to light), which severely debilitates the patients.這是一種罕見形式的慢性過敏性結膜炎看到，在兒童和特點，眼部不適，疼痛，發癢和激烈的photophobia （敏感性輕） ，其中嚴重debilitates病人。
The drug has been classified by the EMEA as an orphan drug.該藥物已被歸類由EMEA地區作為一個孤兒藥物。 The company said that it would file for European Marketing Authorization by mid-2007.該公司說，它將文件為歐洲市場的授權將於2007年年中。
Novagali has several eye treatments undergoing advanced clinical trials. novagali有幾個眼的治療下，先進的臨床試驗。 Its next product will be designed to treat Dry Eye Syndrome.其未來產品將可用於治療幹眼綜合徵。
You may also like to read您也可以想讀
- Phase II Clinical Trial of Mifepristone an Eye Drop Treatment for Steroid Associated Elevated Intraocular Pressure第二期臨床試驗米非司酮1眼藥水治療類固醇相關的高眼壓
- Phase-II Clinical Trial of Drug Evizon for Wet Age-Related Macular Degeneration第一階段和第二臨床試驗的藥物evizon濕年齡相關性黃斑變性
- Can-Fite Begins Phase II Trials for Treatment of Symptoms of Keratitis Sicca (Dry-Eye Syndrome)可以- fite開始二期試驗治療的症狀，乾燥性角膜炎（幹眼綜合徵）
- Epidemic Keratoconjunctivitis Spreading Quickly In Korea流行性角結膜炎迅速蔓延在韓國
- Combination Antibiotic-Steroid for Ocular Inflammation Filed for FDA Approval結合抗生素類固醇為眼內炎症申請FDA批准
- Conductive Keratoplasty (non-Laser Refractive Procedure) Debuts in Denver and Colorado Springs導電性角膜形成術（非激光屈光程序）首次亮相丹佛和科羅拉多斯普林斯
- Lucentis - Wet Macular Degeneration Drug is Highly Successful in Clinical Trials Lucentis藥物-濕性黃斑變性的藥物是非常成功的在臨床試驗中
- Antibiotic Doxycycline Successfully Treats Eye Lymphoma抗生素強力黴素，成功地對待眼淋巴瘤
- Cataract Surgery Program Benefits 6.9 Million Patients白內障手術計劃的好處6900000患者
- Age Related Macular Degeneration May be Prevented with Macugen年齡相關性黃斑變性可預防macugen
